Skip to main content
Premium Trial:

Request an Annual Quote

LSBC Appoints Sainsbury Laboratory Scientist to Scientific Advisory Board; Funds His Research

NEW YORK, June 26 - Large Scale Biology has hired David Baulcombe, a professor at The Sainsbury Laboratory in Norwich, UK, as a consultant and appointed him to the company's scientific advisory board, LSBC said Tuesday.  

"Professor Baulcombe is recognized as a world leader in characterizing the mechanisms of post-transcriptional gene silencing, currently known as RNA interference, and has helped demonstrate the utility of this phenomenon to determine gene function in higher organisms," said Laurence Grill, senior vice president of R&D and co-founder of LSBC, in a statement.

The company will also fund a research program in Baulcombe's laboratory for a period of three years to study next-generation viral-derived gene silencing and overexpression technologies, LSBC said in a statement.

The development comes less than a week after LSBC announced an agreement to license similar viral-derived gene silencing and overexpression technology--which Baulcombe and his colleagues developed--from Plant Bioscience, an intellectual property management company based in Norwich. LSBC plans to use the technology in conjunction with its Geneware plant viral vectors.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.